4.4 Article

Safety of endoscopic ultrasound-guided fine-needle aspiration for pancreatic solid mass in the elderly: A single-center retrospective study

期刊

GERIATRICS & GERONTOLOGY INTERNATIONAL
卷 23, 期 11, 页码 836-841

出版社

WILEY
DOI: 10.1111/ggi.14693

关键词

elderly; endoscopic ultrasound-guided fine-needle aspiration; pancreas; safety; sedation

向作者/读者索取更多资源

This study investigated the safety of EUS-FNA for pancreatic solid masses in patients aged >= 80 years. The results showed that the elderly group required fewer sedation doses and had similar adverse event rates compared to the nonelderly group. There was no significant difference in the decrease of percutaneous oxygen saturation between the two groups.
Aim: There are few reports on the safety of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in the elderly. In this study, we investigated the safety of EUS-FNA for pancreatic solid masses in patients aged >= 80 years. Methods: This is a single-center retrospective study. A total of 600 patients with pancreatic solid masses who underwent EUS-FNA under midazolam-based sedation at our institution between September 2016 and December 2022 were enrolled in this study. Eligible patients were divided into two groups: an elderly group aged >= 80 (n = 84), as well as a nonelderly group aged <= 79 (n = 516). These two groups were compared. Results: The elderly group required significantly fewer midazolam doses for sedation (P < 0.001). Adverse events occurred in eight patients (1.3%), including one (1.2%) and seven (1.4%) in the elderly and nonelderly groups, respectively (P = 0.90). There were no cases of early adverse events in the elderly group and six cases (1.2%) in the nonelderly group (P = 0.32). There was one case of late adverse events in both the elderly and nonelderly groups (P = 0.14), and both were needle tract seeding. There was no significant difference between the two groups in the proportion of cases in which percutaneous oxygen saturation decreased to <= 90% during the EUS-FNA. Conclusions: Our analysis suggests that EUS-FNA for pancreatic solid masses can be safely performed in patients aged >80 years without increasing the adverse event rate compared to nonelderly patients aged <80 years.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据